Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for ACADIA Pharmaceuticals Inc. (ACAD)

« Back to company index

ACAD Chatter Timeline

Stock Ticker for ACAD

Most Active Tweeters for ACAD

UserTweets
@SwingTradeBot 3
@Gambiste1 3
@AmericanBanking 3
@Marko_Sivec 2
@SeasonalEdge 2

Recent Tweets for ACAD

SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $ACAD $POLA ... https://t.co/qwiJH6vr1O
June 17th 2019, 12:06pm
SwingTradeBot @SwingTradeBot
$ACAD technical alerts: Fell Below 20 DMA, Fell Below 50 DMA, MACD Bearish Centerline Cross, MACD... https://t.co/bE2LrE6Q53
June 17th 2019, 8:06am
1MinuteStock @1MinuteStock
Wondering about risks of $ACAD? The 21-day volatility is 13.29% https://t.co/HMcblgz7pY
June 17th 2019, 7:06am
Marko_Sivec @Marko_Sivec
$ACAD Gold medical of the future...#MEDICAL #NUPLAZID #PIMAVANSERIN
June 16th 2019, 4:06pm
dailypoliticaln @dailypoliticaln
Zacks: Brokerages Anticipate ACADIA Pharmaceuticals Inc. $ACAD Will Announce Quarterly Sales of $73.07 Million https://t.co/IRdh47Ls7B
June 16th 2019, 2:06pm
TickerReport @TickerReport
-$0.46 EPS Expected for ACADIA Pharmaceuticals Inc. $ACAD This Quarter https://t.co/zCRWnsWiX8
June 16th 2019, 2:06pm
Gambiste1 @Gambiste1
RT @DataTrials: $ACAD Phase 2 Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression… Estimated Primary Comp…
June 16th 2019, 12:06pm
DataTrials @DataTrials
$ACAD Phase 2 Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression… Estimated Prim… https://t.co/C2YvH9xH0p
June 16th 2019, 11:06am
TranscriptDaily @TranscriptDaily
ACADIA Pharmaceuticals Inc. $ACAD Receives $29.00 Consensus PT from Analysts https://t.co/VkzPIjPWXb
June 16th 2019, 10:06am
dispatchtribune @dispatchtribune
ACADIA Pharmaceuticals $ACAD Shares Down 5.3% https://t.co/m6RKzdNpMd
June 14th 2019, 11:06pm
WeekHerald @WeekHerald
Analysts Expect ACADIA Pharmaceuticals Inc. $ACAD to Announce -$0.46 EPS https://t.co/DHzICIdCzJ
June 14th 2019, 12:06pm
bbnsnews @bbnsnews
ACADIA Pharmaceuticals Inc. $ACAD Expected to Announce Quarterly Sales of $73.07 Million https://t.co/UKO04j6fSt
June 14th 2019, 11:06am
ArthurHill @ArthurHill
The noose is tightening as Acadia Pharma consolidates within an uptrend. $ACAD https://t.co/fTDWcIZ5Aq
June 13th 2019, 9:06am
tq_equities @tq_equities
$ACAD finds support at 50-day moving average: https://t.co/ypBHvq1at6 Sentiment: Neutral #ACAD #Acadia
June 12th 2019, 4:06pm
FlynancialA @FlynancialA
$ACAD so much potential here https://t.co/JwmOLRFpVm
June 12th 2019, 4:06pm
SeasonalEdge @SeasonalEdge
Daily trading range of $ACAD https://t.co/TxSidopxfY https://t.co/L8NjsLz2Gc
June 12th 2019, 10:06am
Gambiste1 @Gambiste1
RT @ForTheRecord01: $acad will report the 2nd largest QoQ growth in Nuplazid's history in early August. 2Q sales are expected to come in ar…
June 12th 2019, 3:06am
ForTheRecord01 @ForTheRecord01
$acad will report the 2nd largest QoQ growth in Nuplazid's history in early August. 2Q sales are expected to come i… https://t.co/nM4Svh1UpT
June 12th 2019, 2:06am
AmericanBanking @AmericanBanking
ACADIA Pharmaceuticals Inc. $ACAD Given Average Recommendation of “Buy” by Brokerages https://t.co/VaFUJYcUta #stocks
June 11th 2019, 12:06pm
ProVesting @ProVesting
$ACAD: ACADIA Pharmaceuticals Inc.’s (NASDAQ:ACAD) Profit Outlook: https://t.co/YDgViaaHVr
June 11th 2019, 7:06am
SeasonalEdge @SeasonalEdge
Today's insight on $ACAD https://t.co/AsUAAjAeF2 https://t.co/5CjrclDLUS
June 11th 2019, 4:06am
AmericanBanking @AmericanBanking
ACADIA Pharmaceuticals Inc. $ACAD Expected to Post Quarterly Sales of $73.07 Million https://t.co/4P1tyogaxF #stocks
June 11th 2019, 1:06am
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Expect ACADIA Pharmaceuticals Inc. $ACAD Will Post Quarterly Sales of $73.07 Million https://t.co/PEp36LDSyw
June 11th 2019, 1:06am
Marko_Sivec @Marko_Sivec
$ACAD Looks very bad,potencial risky...#MEDICAL
June 10th 2019, 6:06pm
MC_OptionTrades @MC_OptionTrades
$ACAD $ACAD 14-Jun-19 Straddle Implies a ±5.4% move. Jun 11 Goldman Sachs 40th Annual Global Healthcare Conference https://t.co/xcWwFDROcm
June 10th 2019, 8:06am
ResearchPool @ResearchPool
$ACAD #ACADIA Pharmaceuticals Inc. ACAD - Embedded Expectations Analysis - 2019 06 10: ACADIA Pharmaceuticals Inc.… https://t.co/wFtgIjFuEb
June 10th 2019, 4:06am
AmericanBanking @AmericanBanking
-$0.46 Earnings Per Share Expected for ACADIA Pharmaceuticals Inc. $ACAD This Quarter https://t.co/tx1BCMBZPI #stocks
June 9th 2019, 8:06pm
bio_stock @bio_stock
@BigChodu I remember a few years ago when $acad backed out of a medical conference and people thought it was a buyo… https://t.co/6GNdBKAh5K
June 9th 2019, 12:06pm
Gambiste1 @Gambiste1
RT @KrstevskiBranko: Nuplazid sales grow by 5.7% quarter over quarter. $ACAD https://t.co/dBKw189Auz
June 9th 2019, 8:06am
SwingTradeBot @SwingTradeBot
Recent $ACAD technical alerts: 180 Bullish Setup plus 14 more alerts... https://t.co/bE2LrE6Q53
June 8th 2019, 9:06am
InsiderAlertsIA @InsiderAlertsIA
$ACAD: New Insider Filing on 10%+ Owner BAKER BROS. ADVISORS LP: https://t.co/DtmAJSFaAO
June 7th 2019, 6:06pm
Biotech2050 @Biotech2050
@RettDad Status of clinical trial by $ACAD in Rett Syndrome https://t.co/N9IM6FHxwu
June 7th 2019, 1:06am
Allstocknews @Allstocknews
$ACAD ACADIA Pharmaceuticals to Present at the Goldman Sachs 40th Annual Global Healthcare Conference From our Stock News Alerts App
June 4th 2019, 9:06am
TheMarketsDaily @TheMarketsDaily
ACADIA Pharmaceuticals $ACAD Price Target Raised to $43.00 at Raymond James https://t.co/23PgvmnI9b
June 4th 2019, 2:06am
SleekMoneycom @SleekMoneycom
ACADIA Pharmaceuticals $ACAD Price Target Raised to $43.00 at Raymond James https://t.co/W3TBvqgSk8 #investing
June 4th 2019, 1:06am
stocknewstimes @stocknewstimes
ACADIA Pharmaceuticals $ACAD Price Target Raised to $43.00 at Raymond James https://t.co/FrGEIzJJ7k
June 4th 2019, 1:06am
revengebets @revengebets
$acad another one how have they not been bought by big pharma $iwm Baker brother has a huge position just surprised
June 3rd 2019, 12:06pm
ConsumerFeed @ConsumerFeed
ACADIA Pharmaceuticals $ACAD PT Raised to $43.00 at Raymond James https://t.co/rEjF6RzBnj
June 3rd 2019, 2:06am
ForTheRecord01 @ForTheRecord01
$acad Studies show that Nuplazid works as well or better than the leading antipsychotics on the market:… https://t.co/7hqx1Ubbud
June 2nd 2019, 3:06pm
ForTheRecord01 @ForTheRecord01
$acad From December 21, 2018 to April 5, 2019, ACAD rose by over 100%. When did the options market predict this mon… https://t.co/7qm9PEx8fW
June 2nd 2019, 3:06pm
dispatchtribune @dispatchtribune
ACADIA Pharmaceuticals $ACAD Price Target Increased to $43.00 by Analysts at Raymond James https://t.co/EoJukDTygb
June 2nd 2019, 2:06am
AmericanBanking @AmericanBanking
ACADIA Pharmaceuticals $ACAD Rating Reiterated by Raymond James https://t.co/f3f5jgMNxa #stocks
May 31st 2019, 5:05pm
ChartMill @ChartMill
An Altman-Z score of 20.99 indicates that $ACAD is not in any danger for bankruptcy at the moment.… https://t.co/inKf1yuMjk
May 30th 2019, 10:05am
SwingTradeBot @SwingTradeBot
$ACAD technical alerts: Expansion Pivot Sell Setup, MACD Bearish Signal Line Cross, MACD Bearish ... https://t.co/bE2LrE6Q53
May 30th 2019, 8:05am
dispatchtribune @dispatchtribune
ACADIA Pharmaceuticals Target of Unusually High Options Trading $ACAD https://t.co/4XQj2JdGGV
May 30th 2019, 7:05am
AmericanBanking @AmericanBanking
ACADIA Pharmaceuticals Target of Unusually High Options Trading $ACAD https://t.co/5PjARHhfH1 #stocks
May 30th 2019, 6:05am
1MinuteStock @1MinuteStock
Do you know that #Book Value for $ACAD is $2.9 https://t.co/bbT80YnLo4
May 30th 2019, 4:05am
SolarMelt @SolarMelt
$ACAD Without that Put Spread we're looking at a Put Call Ratio of only ~3.66. Still, somebody is awfully bearish a… https://t.co/n3iRTg67k2
May 29th 2019, 7:05pm
SolarMelt @SolarMelt
$ACAD You-all seen the Put/Call ratio today? It's a whopping 119.632 (20628/171). Looks pretty frightening. Turns o… https://t.co/7FWlNxLTtQ
May 29th 2019, 7:05pm
FeelTrade @FeelTrade
$ACAD Spet 25/20 Putspread (10K) trading this afternoon.
May 29th 2019, 3:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.